Subacute sclerosing pan encephalitis with different perspective: an atypical case
DOI:
https://doi.org/10.18203/2349-3291.ijcp20254186Keywords:
SSPE, Atypical encephalitis, Myoclonus jerks, NeuroregressionAbstract
Subacute sclerosing pan encephalitis (SSPE) is a rare type of brain disease that happens when a changed version of the measles virus keeps infecting the brain. The symptoms start with changes in behavior, then seizures, trouble thinking, stiff muscles, and eventually, the person might go into a coma and die. A 7-year-old male patient presented in OPD with complaint of single episode of generalized tonic clonic seizures lasting for 30 seconds, followed by left sided upper limb and lower limb weakness along with myoclonic seizures. Patient was active and on walking patient was swaying towards right side. Supportive management with anti-epileptics given but patient has poor prognosis. Our case showed three unusual signs of SSPE: starting at a young age, sudden loss of balance showing a fast disease progress, and happening in a child who had been vaccinated but didn't have a known measles infection. We think the child might have had a mild measles infection that wasn't noticed by the parents, which could have led to SSPE.
Metrics
References
National Operational Guidelines. Measles-Rubella Vaccine Operational Guidelines, 2nd edition New Delhi, India: Ministry of Health and Family Welfare, Government of India. 2017.
Belgamwar RB, Prasad S, Appaya P. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis. J Indian Med Assoc. 1997;95:594.
Shaligram R, Garud BP, Jadhav RS, Chalipat S, Mane S. A Rare Case of Subacute Sclerosing Panencephalitis in an Immunized Patient. Cureus. 2024;16(6):e63258. DOI: https://doi.org/10.7759/cureus.63258
Dyken PR. Subacute sclerosing panencephalitis. Current status. Neurol Clin. 1985;3(1):179-96. DOI: https://doi.org/10.1016/S0733-8619(18)31062-4
Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36(6):1334-48.
Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis. 2005;192(10):1686-93. DOI: https://doi.org/10.1086/497169
Mekki M, Eley B, Hardie D, Wilmshurst JM. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions. Dev Med Child Neurol. 2019;61:1139-44. DOI: https://doi.org/10.1111/dmcn.14166
Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78:63-70. DOI: https://doi.org/10.1136/pmj.78.916.63
Pandit L. Differential diagnosis of white matter diseases in the tropics: an overview. Ann Indian Acad Neurol. 2009;12:12-21.
Jafri SK, Kumar R, Ibrahim SH. Subacute sclerosing panencephalitis-current perspectives. Pediatric Health Med Ther. 2018;9:67-71. DOI: https://doi.org/10.2147/PHMT.S126293
Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334-48. DOI: https://doi.org/10.1093/ije/dym207